193 related articles for article (PubMed ID: 10774587)
21. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
Korba BE; Schinazi RF; Cote P; Tennant BC; Gerin JL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
[TBL] [Abstract][Full Text] [Related]
22. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
23. [Dynamic changes of hepatitis B virus during treatment with lamivudine versus lamivudine plus famciclovir].
Hou J; Fen X; Nie Z
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):81-3. PubMed ID: 10861109
[TBL] [Abstract][Full Text] [Related]
24. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
26. Perspectives for the treatment of hepatitis B virus infections.
De Clercq E
Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
Wang HF; Li L; Su HB; Ji W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):180-2. PubMed ID: 12870005
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
[TBL] [Abstract][Full Text] [Related]
29. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
Papatheodoridis GV; Dimou E; Papadimitropoulos V
Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
[TBL] [Abstract][Full Text] [Related]
30. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
31. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
Michalak TI; Zhang H; Churchill ND; Larsson T; Johansson NG; Oberg B
Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
[TBL] [Abstract][Full Text] [Related]
32. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.
Menne S; Cote PJ
World J Gastroenterol; 2007 Jan; 13(1):104-24. PubMed ID: 17206759
[TBL] [Abstract][Full Text] [Related]
33. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
[TBL] [Abstract][Full Text] [Related]
34. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
Front Immunol; 2021; 12():745802. PubMed ID: 34671360
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic viral hepatitis.
Main J; McCarron B; Thomas HC
Antivir Chem Chemother; 1998 Nov; 9(6):449-60. PubMed ID: 9865383
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Hultgren C; Weiland O; Milich DR; Sällberg M
Clin Infect Dis; 1999 Dec; 29(6):1575-7. PubMed ID: 10585820
[No Abstract] [Full Text] [Related]
38. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection.
Meng Z; Zhang X; Pei R; Zhang E; Kemper T; Vollmer J; Davis HL; Glebe D; Gerlich W; Roggendorf M; Lu M
Antiviral Res; 2016 Jan; 125():14-24. PubMed ID: 26585244
[TBL] [Abstract][Full Text] [Related]
39. The woodchuck model of hepatitis B virus infection.
Tennant BC; Gerin JL
ILAR J; 2001; 42(2):89-102. PubMed ID: 11406711
[TBL] [Abstract][Full Text] [Related]
40. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
